blinatumomab
Showing 26 - 50 of 59
Philadelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALL Trial in Spain (blinatumomab)
Terminated
- Philadelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALL
- blinatumomab
-
Badalona, Barcelona, Spain
- +11 more
Jul 26, 2022
Acute Lymphoblastic Leukemia Trial in Worldwide (Blinatumomab, AMG 404, Dexamethasone Premedication)
Active, not recruiting
- Acute Lymphoblastic Leukemia
- Blinatumomab
- +2 more
-
Duarte, California
- +18 more
Jul 27, 2022
B-cell Acute Lymphoblastic Leukemia Trial in Tampa, Durham, Winston-Salem (Blinatumomab)
Withdrawn
- B-cell Acute Lymphoblastic Leukemia
- Blinatumomab
-
Tampa, Florida
- +2 more
Feb 14, 2022
ALL, Adult Trial in Belgium, Netherlands (Blinatumomab)
Active, not recruiting
- ALL, Adult
- Blinatumomab
-
Antwerpen, Belgium
- +17 more
Dec 29, 2021
B-cell Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, B-Cell ALL, Childhood Trial in Milwaukee
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- +2 more
- Alpha/Beta T-cell and B-cell depleted HCT
- Blinatumomab
-
Milwaukee, WisconsinChildren's Hospital of Wisconsin
Sep 12, 2021
Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), MDS (MDS) Trial in Memphis (drug, biological, device)
Recruiting
- Acute Lymphoblastic Leukemia (ALL)
- +7 more
- Cyclophosphamide
- +11 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 8, 2021
Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Memphis (drug, biological, radiation)
Not yet recruiting
- Refractory Acute Lymphoblastic Leukemia
- Relapsed Acute Lymphoblastic Leukemia
- Venetoclax
- +16 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Aug 23, 2022
Philadelphia-Negative ALL, High-Risk Cancer Trial in Israel (Blinatumomab)
Recruiting
- Philadelphia-Negative ALL
- High-Risk Cancer
- Blinatumomab
-
Haifa, Israel
- +3 more
May 6, 2021
Non-Hodgkin Lymphoma Trial in Boston (Blinatumomab)
Active, not recruiting
- Non-Hodgkin Lymphoma
- Blinatumomab
-
Boston, MassachusettsMassachusetts general Hospital
Jan 31, 2021
B Acute Lymphoblastic Leukemia Trial (procedure, biological, drug, radiation)
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- Biospecimen Collection
- +19 more
- (no location specified)
Nov 8, 2023
Philadelphia Chromosome Negative, Recurrent B Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia Trial in
Terminated
- Philadelphia Chromosome Negative
- +2 more
- Blinatumomab
- +11 more
-
Houston, TexasM D Anderson Cancer Center
Nov 3, 2022
Leukemia, B-cell, Lymphoma, B-Cell Trial in Cincinnati (Blinatumomab, Pembrolizumab)
Withdrawn
- Leukemia, B-cell
- Lymphoma, B-Cell
- Blinatumomab
- Pembrolizumab
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Mar 30, 2021
Acute Lymphoblastic Leukemia, Adult Trial (Ponatinib, Blinatumomab, Imatinib)
Not yet recruiting
- Acute Lymphoblastic Leukemia, Adult
- Ponatinib
- +2 more
- (no location specified)
Dec 28, 2020
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia With
Recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +5 more
- Blinatumomab
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Feb 1, 2022
Acute Lymphoblastic Leukemia Trial (Tisagenlecleucel, Blinatumomab, Inotuzumab)
Withdrawn
- Acute Lymphoblastic Leukemia
- Tisagenlecleucel
- +2 more
- (no location specified)
Jul 7, 2020
B-Cell Non Hodgkin Lymphoma Trial in Worldwide (Blinatumomab)
Completed
- B-Cell Non Hodgkin Lymphoma
- Blinatumomab
-
Duarte, California
- +30 more
Dec 18, 2020
Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia Trial in Worldwide (Blinatumomab, Standard of Care Chemotherapy)
Terminated
- Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
- Blinatumomab
- Standard of Care Chemotherapy
-
Duarte, California
- +116 more
Jan 4, 2022
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia Trial in Worldwide (radiation, biological, drug)
Suspended
- Down Syndrome
- Recurrent B Acute Lymphoblastic Leukemia
- 3-Dimensional Conformal Radiation Therapy
- +13 more
-
Birmingham, Alabama
- +202 more
Jan 17, 2023
Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma Trial in Australia, United States (Prednisone, Vincristine,
Recruiting
- Acute Lymphoblastic Leukemia
- Acute Lymphoblastic Lymphoma
- Prednisone
- +21 more
-
Palo Alto, California
- +6 more
May 2, 2022
Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative Trial in Worldwide (procedure,
Active, not recruiting
- Acute Lymphoblastic Leukemia
- B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
- Allogeneic Hematopoietic Stem Cell Transplantation
- +15 more
-
Birmingham, Alabama
- +550 more
Jan 28, 2023
Multiple Myeloma Trial in Philadelphia (Blinatumomab)
Terminated
- Multiple Myeloma
- Blinatumomab
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Feb 5, 2020
High-risk Diffuse Large B-cell Lymphoma Trial in Worldwide (Blinatumomab)
Terminated
- High-risk Diffuse Large B-cell Lymphoma
- Blinatumomab
-
Atlanta, Georgia
- +31 more
Sep 10, 2020
Childhood Acute Lymphoblastic Leukemia Trial in Moscow, Saint Petersburg (Blinatumomab)
Recruiting
- Childhood Acute Lymphoblastic Leukemia
- Blinatumomab
-
Moscow, Russian Federation
- +3 more
Jan 22, 2021
High-risk DLBCL Trial in Worldwide (Blinatumomab, Investigator's Choice Chemotherapy, Dexamethasone)
Completed
- High-risk Diffuse Large B-Cell Lymphoma
- Blinatumomab
- +2 more
-
Chicago, Illinois
- +23 more
Aug 26, 2020